<!doctype html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <link rel="stylesheet" href="../../../../../../../../static/css/lato.css">
    <link rel="stylesheet" href="../../../../../../../../static/css/bootstrap-superhero.min.css">
    <link rel="stylesheet" href="../../../../../../../../static/css/archive.css">
    <title>r/nootopics: Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo</title>
  </head>
  <body>
    <header>
      <nav class="navbar navbar-expand-sm navbar-dark bg-primary">
        <a class="navbar-brand" href="../../../../../../../../nootopics/index.html">r/nootopics</a>
        <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation">
          <span class="navbar-toggler-icon"></span>
        </button>
        <div class="collapse navbar-collapse" id="navbarNav">
          <ul class="navbar-nav">
            <li class="nav-item">
              <a class="nav-link" href="../../../../../../../../nootopics/index.html">score</a>
            </li>
            <li class="nav-item">
              <a class="nav-link" href="../../../../../../../../nootopics/index-comments/index.html">comments</a>
            </li>
            <li class="nav-item">
              <a class="nav-link" href="../../../../../../../../nootopics/index-date/index.html">date</a>
            </li>
            <li class="nav-item ###URL_SEARCH_CSS###">
              <a class="nav-link" href="../../../../../../../../nootopics/search.html">search</a>
            </li>
            <li class="nav-item dropdown">
              <a class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">subreddits</a>
              <div class="dropdown-menu" aria-labelledby="navbarDropdown">
                <a class="dropdown-item" href="../../../../../../../../index.html">All</a>
                <a class="dropdown-item" href="../../../../../../../../nootopics/index.html">nootopics</a>
              </div>
            </li>
          </ul>
        </div>
      </nav>
    </header>
    <main role="main" class="container-fluid">
      <div class="submission pt-3" data-id="xyd0hv">
        <h3 class="title"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103325/">Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo</a></h3>
        <p><span class="badge badge-primary">10</span>&nbsp;&nbsp;2022-10-07 by <a class="author" href="../../../../../../../../user/Alhakawati.html">Alhakawati</a></p>
        
      </div>
      <div class="comments">
        <h5>30 comments</h5>
        <div class="comment mb-3 ml-0 op" data-depth="0" data-id="irgjsg0">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">6</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/Alhakawati.html">Alhakawati</a> 2022-10-07</p>
    <div class="md"><p>How does one, upregulates/increase vmat2?</p>

<p>we generated VMAT2-overexpressing mice using a bacterial artificial chromosome (BAC) to determine whether increased vesicular packaging could provide an elevation of monoamine output in a mammalian system. We report here that VMAT2-overexpressing mice (VMAT2-HI) have increased vesicle capacity, increased synaptic dopamine release, improved outcomes on anxiety-like and depressive-like behaviors, and reduced vulnerability to toxic insult by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). These data demonstrate that the manipulation of vesicular capacity is capable of providing a sustained enhancement of the dopamine system and suggest that the vesicle is a viable therapeutic target for numerous monoamine-deficient disorders.</p>

<p>Because VMAT2-HI mice show both increased dopamine release and increased extracellular dopamine levels, we anticipated that there would be compensatory changes to DAT or other dopamine mediators. However, VMAT2-HI mice show no differences in levels of DAT or TH (Fig. S2), nor in indirect estimates of transmitter clearance by voltammetry (rate constant, tau) and microdialysis (extraction fraction). These data suggest that the enhancement of the dopamine system is sustained without major compensatory changes to other mediators of presynaptic dopamine dynamics in the VMAT2-HI mice. In addition, VMAT2-HI mice display and maintain monoamine-mediated behavioral phenotypes, suggesting that receptor levels or function have not overcome these presynaptic alterations.</p>
</div>
</div>
<div class="comment mb-3 ml-1" data-depth="1" data-id="iricze0">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">6</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/veryverum.html">veryverum</a> 2022-10-07</p>
    <div class="md"><p>Upregulation of VMAT2 is a very good candidate for a gene therapy against depression, anhedonia, anxiety, etc.. possibly safe and sustainable way of increasing our quality of life and performance. Can&#39;t wait for VMAT2-HI humans. I think it&#39;s possible that there already are people with gene mutation that leads to upregulated VMAT2, similarly to the people with FAAH-OUT gene mutation.</p>
</div>
</div>
<div class="comment mb-3 ml-2 op" data-depth="2" data-id="j1b6f6c">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">2</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/Alhakawati.html">Alhakawati</a> 2022-10-07</p>
    <div class="md"><p>Now when I think about it, I do also believe people do have some sort of mutation that leads to upregulated vmat2. I have a friend, who&#39;s pretty much always high on life and full of energy, doesn&#39;t drink caffeine or smoke or alcohol or any substance/supplement, but he&#39;s always full of energy and no matter what situation he is in, he is never stressed.
Extremely highly motivated and ambitious and is extremely successful and he built it all himself, came from a very low socio-economic class, I guess it&#39;s definitely a mix of nature/nurture. But I can tell his dopamine is so high, always has plans for the future, always moving forward, always about what&#39;s next.</p>
</div>
</div>
<div class="comment mb-3 ml-0" data-depth="0" data-id="irgzz86">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">2</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/Snoo-82170.html">Snoo-82170</a> 2022-10-07</p>
    <div class="md"><p>I didn&#39;t understand. Wouldn&#39;t increasing VMAT2 cause more monoamines to be pulled out of the synapse? Or by the increase, does he mean the decrease in transporter activity?</p>
</div>
</div>
<div class="comment mb-3 ml-1" data-depth="1" data-id="iri2szb">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/veryverum.html">veryverum</a> 2022-10-07</p>
    <div class="md"><p>From what I understand VMAT2 &quot;operates&quot; inside cells and it transports monoamines from cellular cystol into synaptic vesicles, both of which are inside a cell. Synaptic vesicles is where neurotransmitters are stored before they are released into the synaptic cleft.</p>
</div>
</div>
<div class="comment mb-3 ml-2" data-depth="2" data-id="iri9elz">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/Snoo-82170.html">Snoo-82170</a> 2022-10-07</p>
    <div class="md"><p>o the increase in the transporter would make more monoanimas &#39;enter&#39; the vesicles, to be released later, would that be it?</p>
</div>
</div>
<div class="comment mb-3 ml-3" data-depth="3" data-id="iribvxz">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">2</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/veryverum.html">veryverum</a> 2022-10-07</p>
    <div class="md"><p>Yes, that&#39;s my understanding. And also from the study it seems upregulation of the VMAT2 increase the vesicle capacity to store neurotransmitters.</p>
</div>
</div>
<div class="comment mb-3 ml-3" data-depth="3" data-id="irm6mya">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/AromaticPlant8504.html">AromaticPlant8504</a> 2022-10-07</p>
    <div class="md"><p>Allows for the sequestration of dopamine and other neurotransmitter so they don‚Äôt spontaneously oxidise</p>
</div>
</div>
<div class="comment mb-3 ml-0" data-depth="0" data-id="irhfzzj">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">2</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/funkehfresh.html">funkehfresh</a> 2022-10-07</p>
    <div class="md"><p>I&#39;m understanding that there is some likelihood that moderate upregulation of dopamine influx to the synapse, and activity at post synaptic receptors, will not cause an equal and opposite compensatory downregulation. Rather, the net effect may be likely that the overall system is upregulated, functioning better than it otherwise would or ever could. This is exactly what amphetamine achieves, except by reversing DAT, which functions then effectively as VMAT. This is an incredible study. Soon everyone will be on speed. Most of us are already.</p>
</div>
</div>
<div class="comment mb-3 ml-1 op" data-depth="1" data-id="irhiv2i">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">4</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/Alhakawati.html">Alhakawati</a> 2022-10-07</p>
    <div class="md"><p>I don&#39;t understand what you mean by the last point? I thought amphetamines inhibit VMAT2, then reverse DAT, Aswell over expressed VMAT2 in mice protects striatal dopamine system from meth toxicity?
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489556/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489556/</a></p>
</div>
</div>
<div class="comment mb-3 ml-2" data-depth="2" data-id="irhjac1">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">2</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/funkehfresh.html">funkehfresh</a> 2022-10-07</p>
    <div class="md"><p>The net effect of the overactivity of VMAT in this study is the same as is seen in the presence of amphetamine; increased post-synaptic activation. The leverage points differ, which seems to be a secondary detail. That is until we are able to manipulate human genetics as was done to these lucky mice. What I learned here is that the dopamine system can be upregulated permanently and sustainably. That is an amazing discovery. Still, if I could choose the gene edit option, I&#39;d be down dude lol fuck speed if I can just turn up the dopamine hose genetically.</p>
</div>
</div>
<div class="comment mb-3 ml-3 op" data-depth="3" data-id="irhnd2h">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">3</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/Alhakawati.html">Alhakawati</a> 2022-10-07</p>
    <div class="md"><p>That&#39;s the goal, to upregulates it sustainably!
I hope one day we will be able to do this with the dopamine system! The question is, what can we do now, or is there something being developed or shelved that upregulates vmat2 ? Only things i could find are Kanna and a comment on thymoquinone upregulates vmat2. Agreed!</p>
</div>
</div>
<div class="comment mb-3 ml-4" data-depth="4" data-id="irhqfk6">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">2</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/funkehfresh.html">funkehfresh</a> 2022-10-07</p>
    <div class="md"><p>Amphetamine. Different mechanism, same outcome. There is loads of evidence that low-moderate dose stimulant use is healthy for the brain. I dare to assert that it&#39;s more likely to be helpful than harmful in the presence of proper risk-insulation, most especially from risk of abuse. Abuse of stimulants is detrimental and should be avoided at all costs, which hardly needs to be said.</p>
</div>
</div>
<div class="comment mb-3 ml-5" data-depth="5" data-id="irj9iaa">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">2</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/EchoingSimplicity.html">EchoingSimplicity</a> 2022-10-07</p>
    <div class="md"><p>What counts as a low dose?</p>
</div>
</div>
<div class="comment mb-3 ml-6" data-depth="6" data-id="irjjld7">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/funkehfresh.html">funkehfresh</a> 2022-10-07</p>
    <div class="md"><p>Only the body can answer that. And the mind tends to pretend to be the whole body, rather than just a part of it. If the mind has an appetite greater than the body, then that will supersede. So there is risk.</p>
</div>
</div>
<div class="comment mb-3 ml-7" data-depth="7" data-id="irjntqb">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">2</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/EchoingSimplicity.html">EchoingSimplicity</a> 2022-10-07</p>
    <div class="md"><p>Cool but you were talking about scientific studies. What doses were used in these studies?</p>
</div>
</div>
<div class="comment mb-3 ml-8" data-depth="8" data-id="irmlxhv">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/funkehfresh.html">funkehfresh</a> 2022-10-07</p>
    <div class="md"><p>In the first study, for an 80kg person like me, the doses used are roughly 20mg, 40mg, and 160mg per day. It suggests that amphetamine may facilitate neurogenesis to some degree. I speculate, and maybe they touch on this somewhere in this study, that the lower two doses would provide the most benefit with the least detrimental side effects. The second study is more of the same.</p>

<p>I remember a study that found neuroprotective effects too but I&#39;ll find it later.</p>

<p><a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C7&amp;q=neurogenesis+and+amphetamine+&amp;btnG=#d=gs_qabs&amp;t=1665318980186&amp;u=%23p%3DVBMh2kUKlfwJ">https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C7&amp;q=neurogenesis+and+amphetamine+&amp;btnG=#d=gs_qabs&amp;t=1665318980186&amp;u=%23p%3DVBMh2kUKlfwJ</a></p>

<p><a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C7&amp;q=neurogenesis+and+amphetamine+&amp;btnG=#d=gs_qabs&amp;t=1665323045319&amp;u=%23p%3Dju6jJrPLqSAJ">https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C7&amp;q=neurogenesis+and+amphetamine+&amp;btnG=#d=gs_qabs&amp;t=1665323045319&amp;u=%23p%3Dju6jJrPLqSAJ</a></p>
</div>
</div>
<div class="comment mb-3 ml-5" data-depth="5" data-id="irk7dt6">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">2</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/holymoleysmokeyjoey.html">holymoleysmokeyjoey</a> 2022-10-07</p>
    <div class="md"><p>But when you say upregulate, do you mean a sustained upregulation of the system that will prevail and lead to long-term beneficial adaptation, or do you mean a transient adaptation which will lead to hypofunction when the stimulant is withdrawn?</p>
</div>
</div>
<div class="comment mb-3 ml-6" data-depth="6" data-id="irkj1qa">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/funkehfresh.html">funkehfresh</a> 2022-10-07</p>
    <div class="md"><p>First is the best case scenario and seems pretty unlikely. More likely the second. I&#39;m happy with transient. Just gotta be patient for the genetic therapies just around the corner. If I ever begin to CRISPR myself I&#39;ll keep the homies posted.</p>
</div>
</div>
<div class="comment mb-3 ml-7" data-depth="7" data-id="irv3gc2">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/holymoleysmokeyjoey.html">holymoleysmokeyjoey</a> 2022-10-07</p>
    <div class="md"><p>üê∏</p>
</div>
</div>
<div class="comment mb-3 ml-2" data-depth="2" data-id="irk76s0">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/holymoleysmokeyjoey.html">holymoleysmokeyjoey</a> 2022-10-07</p>
    <div class="md"><p>I thought amphets upregulate DAT to take dopamine out of the synapse ASAP to compensate for the hyperactivity?</p>
</div>
</div>
<div class="comment mb-3 ml-0" data-depth="0" data-id="irhrfit">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">2</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/Zeezprahh.html">Zeezprahh</a> 2022-10-07</p>
    <div class="md"><p>My adhd needs this, hand it over!</p>
</div>
</div>
<div class="comment mb-3 ml-0" data-depth="0" data-id="iri3pbn">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/veryverum.html">veryverum</a> 2022-10-07</p>
    <div class="md"><p>Mesembrine upregulates VMAT2, it is an alkaloid present in Sceletium tortuosum (kanna). </p>

<p>&quot;VMAT-2 was upregulated significantly in response to Sceletium treatment&quot;</p>

<p><a href="https://www.sciencedirect.com/science/article/abs/pii/S0378874115302348">https://www.sciencedirect.com/science/article/abs/pii/S0378874115302348</a></p>
</div>
</div>
<div class="comment mb-3 ml-1" data-depth="1" data-id="irk7keo">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/holymoleysmokeyjoey.html">holymoleysmokeyjoey</a> 2022-10-07</p>
    <div class="md"><p>Have you experimented with kanna and noticed anything that might suggest that dopaminergic activity is being enhanced?</p>
</div>
</div>
<div class="comment mb-3 ml-2" data-depth="2" data-id="irlyhe3">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">2</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/veryverum.html">veryverum</a> 2022-10-07</p>
    <div class="md"><p>Yes, high mesembrine extracts definitely have dopaminergic activity. Moreover, mesembrine and the other Kanna alkaloids also inhibit serotonin transporter, so the overall subjective effect of kanna is dopaminergic and serotonergic. Depending on the ratio of the alkaloids in the extract, the effect will be more dopaminergic (mesembrine) or more serotonergic (mesembrenone).</p>
</div>
</div>
<div class="comment mb-3 ml-3" data-depth="3" data-id="irv3dt8">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/holymoleysmokeyjoey.html">holymoleysmokeyjoey</a> 2022-10-07</p>
    <div class="md"><p>Can you recommend a good brand? I was looking at that doctor&#39;s choice or whatever it&#39;s called, they have some sort of patented form</p>
</div>
</div>
<div class="comment mb-3 ml-4" data-depth="4" data-id="irvr9xi">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/veryverum.html">veryverum</a> 2022-10-07</p>
    <div class="md"><p>Yes, that&#39;s Zembrin. It is standardized to contain 0.35‚Äì0.45% total alkaloids (mesembrenone and mesembrenol ‚â•60%, and mesembrine &lt;20%). </p>

<p>There are other stronger extracts that are standardized to higher alkaloid content (up to 6% alkaloids) with mesembrine being the primary alkaloid (&gt;70%). Liftmode&#39;s MT55 and ultrakanna&#39;s ET2 and ET2-Zspec are the most favorite ones in the Kanna community.</p>
</div>
</div>
<div class="comment mb-3 ml-5" data-depth="5" data-id="is7ftdg">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/holymoleysmokeyjoey.html">holymoleysmokeyjoey</a> 2022-10-07</p>
    <div class="md"><p>Do we know if the upregulation of VMAT2 is sustained after cessation, or is it an acute effect only?</p>
</div>
</div>
<div class="comment mb-3 ml-6" data-depth="6" data-id="isf22jy">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">1</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/veryverum.html">veryverum</a> 2022-10-07</p>
    <div class="md"><p>I don&#39;t think there is any research yet.</p>
</div>
</div>
<div class="comment mb-3 ml-3 op" data-depth="3" data-id="irhnd2h">
    <p class="byline text-muted mb-0"><a href="javascript:;" class="score"><span class="badge badge-secondary">3</span></a>&nbsp;&nbsp;<a class="author" href="../../../../../../../../user/Alhakawati.html">Alhakawati</a> 2022-10-07</p>
    <div class="md"><p>That&#39;s the goal, to upregulates it sustainably!
I hope one day we will be able to do this with the dopamine system! The question is, what can we do now, or is there something being developed or shelved that upregulates vmat2 ? Only things i could find are Kanna and a comment on thymoquinone upregulates vmat2. Agreed!</p>
</div>
</div>

      </div>
    </main>
    <footer class="container-fluid">
      <a class="to-top mt-1 mb-1 btn btn-lg btn-primary" href="#top">top of page</a>
      <p class="small mb-0">data archived 2024-03-08. <a href="https://github.com/libertysoft3/reddit-html-archiver">source code</a>.</p>
    </footer>
    <script src="../../../../../../../../static/js/jquery-3.3.1.slim.min.js"></script>
    <script src="../../../../../../../../static/js/bootstrap.min.js"></script>
    <script src="../../../../../../../../static/js/archive-comments.js"></script>
  </body>
</html>